Please login to the form below

Not currently logged in
Email:
Password:

Quantum Pharma promotes Chris Rigg to chief financial officer

He succeeds Martin Such in the role

Quantum Pharma Chris RiggsDurham, UK-based Quantum Pharma has promoted Chris Rigg from group strategic director to chief financial officer and board member following the resignation of Martin Such earlier this month.

Rigg joined the pharmaceutical manufacturer in November 2015 from NRG, a national recruitment agency, where he had served as chief executive officer since 2013.

He brings 20 years of financial and managerial experience to the role, having worked at Deloitte, Eaga, PriceWaterhouseCoopers and Barclays, where he headed up its North East corporate banking division.

Andrew Scaife, chief executive officer at Quantum, said: “We are delighted to welcome Chris to the board as chief financial officer.

“Chris has a wealth of relevant experience in management, finance and strategic matters and … a good understanding of the group's businesses.

“On behalf of the board I would like to extend sincere thanks to Martin Such for his significant contribution to the success and growth of the company during the past eight years and, in particular, to its listing in 2014.”

18th March 2016

From: Sales

Share

Tags

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Syneos Health®

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and...

Latest intelligence

EU health fund
An EU emergency health fund to limit the impact of future crises
Leading finance experts propose an Emergency Health Financing Facility to limit the impact of future crises on the EU...
Mistrust in medical research: a patient perspective
The recent development of several COVID-19 vaccines has placed medical research firmly in the spotlight, highlighting public confusion and misinformation about clinical trials. Patient advocate, Trishna Bharadia reveals what the...
Real-world evidence: breaking boundaries in rare disease
Generating data for drug launches is a challenging process. In rare diseases, with small patient populations and high unmet need, evidence generation is even more complex. Consultant Sarah Poole and...

Infographics